Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-10T08:19:50.906Z Has data issue: false hasContentIssue false

LSD: 1967

Published online by Cambridge University Press:  29 January 2018

Glin Bennet*
Affiliation:
Department of Mental Health, University of Bristol

Extract

It is twenty years since the appearance of Stoll's paper: “Lysergic acid diethylamide, a hallucinatory agent of the ergot group” (23). In this he sought to reproduce in a group of subjects Hofmann's personal experiences of the drug, and so set the LSD snowball on its way. Some 1,500 papers must by now have been gathered to it; they deal with a greater range of uses than has been thought of for any drug, a greater variety of benefits and disasters, and a confusing number of claims. Yet we have little hard information about this curious substance.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1968 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Blum, R. (1964). In: Utopiates, London: R. Blum and Associates.Google Scholar
2. Blum, R. (1964). Ibid., pp. 7276, pp. 100–105.Google Scholar
3. Blum, R. (1964). Ibid., pp. 9698.Google Scholar
4. Brit. med. J. (1898). i, 390.Google Scholar
5. Cohen, A. Y. (1966). “Who takes LSD and why?New Society, 8, 202.Google Scholar
6. Cohen, M. M., Marinello, M. J., and Back, N. (1967). “Chromosomal damage in human leukocytes induced by lysergic acid diethylamide.” Science, 155, 14171419.CrossRefGoogle ScholarPubMed
7. Cohen, S. (1960). “Lysergic acid diethylamide: side effects and complications.” J. nerv. ment. Dis., 130, 3040.CrossRefGoogle ScholarPubMed
8. Cohen, S. (1964). Drugs and Hallucination. p. 221. London.Google Scholar
9. Cohen, S. (1964). Ibid., p. 217.Google Scholar
10. Cohen, S. (1966). “A classification of LSD complications.” Psychosomatics, 7, 182186.CrossRefGoogle ScholarPubMed
11. Ditman, K. S., Hayman, M., Whittlesey, J. R. B. (1962). “Nature and frequency of claims following LSD.” J. nerv. ment. Dis., 134, 346352.CrossRefGoogle Scholar
12. Ellis, H. (1897). “Mescal: a new artificial paradise.” Annual Report Smithsonian Institution, 537548.Google Scholar
13. Frosch, W. A., Robbins, E. S., and Stern, M. (1965). “Untoward reactions to lysergic acid diethylamide (LSD) resulting in hospitalization.” New Engl. J. Med., 372, 12351239.CrossRefGoogle Scholar
14. Huxley, A. (1956). Heaven and Hell. p. 64. London.Google Scholar
15. James, W. (1896). The Will to Believe and Other Essays. p. 294. London.Google Scholar
16. James, W. (1902). Varieties of Religious Experience, p. 388. London.Google Scholar
17. Laski, M. (1961). Ecstasy: A Study of Some Secular and Religious Experiences. p. 263. London.Google Scholar
18. Leuner, H. (1963). “Psychotherapy with hallucinogens.” In: Hallucinogenic Drugs and their Psychotherapeutic Use. (Eds. Crockett, et al.) London.Google Scholar
19. Masters, R. E. L., and Houston, J. (1967). Varieties of Psychedelic Experience. London.Google Scholar
20. Masters, R. E. L., and Houston, J. (1967). Ibid., p. 247.Google Scholar
21. Mitchell, S. W. (1896). “Remarks on the effects of Anhalonium Lewinii (the mescal button).” Brit. med. J., ii, 16251629.CrossRefGoogle Scholar
22. Spencer, A. M. (1963). “Permissive group therapy with lysergic acid diethylamide.” Brit. J. Psychiat., 109, 3745.CrossRefGoogle ScholarPubMed
23. Stoll, W. A. (1947). “Lysergsäure-diäthyl-amid, ein Phantastikum aus der Mutterkorngruppe.” Schweiz. Arch. Neurol. Psychiat., 60, 279323.Google Scholar
24. The Acts of the Apostles, Ch. 22, v. 6.Google Scholar
25. Zaehner, R. C. (1957). Mysticism: Sacred and Profane. Oxford.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.